Back
Cyclacel Pharmaceuticals Stock Predictions
Sell
47
CYCC
Cyclacel Pharmaceuticals
Last Price:
2.29
Seasonality Move:
-13.89%
7 Day Trial
ALL ACCESS PASS
$
7
Cyclacel Pharmaceuticals Stock Forecast
-
Is Cyclacel Pharmaceuticals Stock Undervalued?
The current Cyclacel Pharmaceuticals [CYCC] share price is $2.29. The Score for CYCC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal. - CYCC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Cyclacel Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Cyclacel Pharmaceuticals Stock Rating
Data Unavailable
Cyclacel Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cyclacel.com
52-Week Data
52-Week High:
13.20
52-Week Low:
1.30
Prediction Charts
Market Cap:
3.02M
Price in USD:
2.29
Volume:
32.64K
Beta:
1.59
Technical Analysis
SMA50:
2.15
SMA100:
2.33
SMA200:
4.25
52-Wk Change:
-76.51%
Stock Predictions
-
Is Cyclacel Pharmaceuticals stock public?
Yes, Cyclacel Pharmaceuticals is a publicly traded company. -
What is the Cyclacel Pharmaceuticals stock quote today?
The Cyclacel Pharmaceuticals stock price is 2.29 USD today. -
How to buy Cyclacel Pharmaceuticals stock online?
You can buy Cyclacel Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 1.93 | 2.12 | 2.29 | 1.74 |
May-1 | 1.90 | 2.68 | 4.00 | 1.89 |
May-2 | 2.50 | 2.48 | 3.15 | 2.44 |
May-3 | 2.37 | 2.00 | 2.52 | 1.94 |
May-6 | 1.94 | 2.08 | 2.20 | 1.93 |
May-7 | 2.07 | 2.11 | 2.18 | 2.02 |
May-8 | 2.13 | 2.32 | 2.50 | 2.06 |
May-9 | 2.35 | 2.31 | 2.60 | 2.27 |
May-10 | 2.22 | 2.27 | 2.30 | 2.16 |
May-13 | 2.46 | 2.54 | 2.72 | 2.37 |
May-14 | 2.22 | 2.84 | 2.84 | 2.22 |
May-15 | 2.81 | 2.44 | 2.81 | 2.30 |
May-16 | 2.39 | 2.34 | 2.48 | 2.25 |
May-17 | 2.28 | 2.29 | 2.40 | 2.23 |
Cyclacel Pharmaceuticals Earnings
Data Unavailable
Cyclacel Pharmaceuticals Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $4.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $21.67 per share, and an increase next year of $1.36 per share.
* Cyclacel Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.